Skip to content

WellCareChina

Independent medical information for international patients

Menu

Disease

Non-Hodgkin lymphoma非霍奇金淋巴瘤

ICD-10: C82–C85 — Non-Hodgkin lymphoma

Group: Cancer Specialty: Hematology

Key figures

Published values only. Every tile opens the section that carries its source, its year and its caliber.

Disease details

Standard Chinese name
非霍奇金淋巴瘤
English name
Non-Hodgkin lymphoma

Values written in Chinese are quoted as published by the source.

Also known as

  • Non-Hodgkin lymphoma
  • NHL

Treatment cost ranges

Every range below is published on one billing basis: Pre-reimbursement 医保报销前. The sources publish no post-reimbursement figure, so none is shown here.

Treatment path Cost range Price basis Data year
Chemotherapy 化疗 60000 – 60000 CNY Condition package price 病种打包全包价 2020
Chemotherapy 化疗 37000 – 37200 CNY Condition package price 病种打包全包价 2020

The bars share one scale across the rows above: each starts at that row's lower published figure and ends at its upper one. The highest upper figure on this page is 60000 CNY. Each row keeps its own data year and caliber.

2 cost ranges for this condition, each with its source on the row page.

Values written in Chinese are quoted as published by the source.

See all cost ranges →

Five-year survival

5-year survival rate 40.8%

Population
Overall (all stages combined) · Age-standardised relative survival 总体（全分期合并）· 年龄标准化相对生存率
Period
2019–2021
Publisher
National Cancer Center 国家癌症中心
Value nature
Estimated value (hybrid analysis) 估计值（混合法）
Registry scope
281 population-based cancer registries 281 个肿瘤登记处
Stage data availability
Not published

Values written in Chinese are quoted as published by the source.

See all survival rates →

How to read this figure. It is published for all stages combined, so it is an average over everyone in the national registry data rather than a prognosis for one person. For most cancers, the stage at diagnosis is the strongest single factor behind survival differences: survival is generally higher when the cancer is found at an earlier stage and lower when it is found later. Comparisons between cancers are also shaped by how early or late each one tends to be diagnosed, so a lower figure does not by itself mean worse care.

Hospitals with a published record for this condition

Selected using official public data sources

These hospitals are selected from official public data sources — the Fudan University hospital specialty reputation rankings, the national key clinical specialties list and national clinical research centres — so each line on a card can be checked against its published source. This is not a paid or promoted listing.

How these hospitals were selected

Admission. A hospital is listed for a condition when the specialty that condition is filed under carries at least one of: a place or a nomination in the Fudan University hospital specialty reputation ranking; a national key clinical specialty record at level A, B or C; or a national clinical research centre or a state key laboratory in that specialty. JCI accreditation is shown as a badge; it never decides admission and it never decides order.

Order. Step 1: a Fudan place between 1 and 10 for the specialty. Step 2: another Fudan place, or a nomination. Step 3: a level-A national key clinical specialty. Step 4: a level-B national key clinical specialty. Step 5: a national clinical research centre or a state key laboratory in the specialty, a centre before a laboratory. Step 6: a level-C national key clinical specialty, which is a record we publish without an independent official source and which is therefore listed after the others.

Ties. Within one step: the better Fudan place first, then the stronger key-specialty level (A before B before C), then the province, then the city, then the hospital name - the same province-city-name order the hospital directory uses. At most eight hospitals are listed.

When the list is short. Five hospitals or more: the first eight are listed. Three or four: all of them are listed, and a further fold adds the remaining records up to eight, each carrying its evidence level. One or two: the same, with that fold open and a line stating how many hospitals have a strong public record. None: the page states that no strong public record was found and links to the specialty directory. A place, an institution or a count is never invented to fill the list.

The Fudan rankings are the hospital specialty reputation ranking most widely recognised by Chinese clinicians, published annually by Fudan University's hospital management institute.

  1. West China Hospital, Sichuan University四川大学华西医院

    Chengdu 成都市

    National key clinical specialty

    Also ranked: General Surgery #3, Thoracic Surgery #4, Urology #2 (tied) in the Fudan list.

  2. Qilu Hospital of Shandong University山东大学齐鲁医院

    Jinan 济南市

    National key clinical specialty

    Also ranked: Gynecology #7 (tied), Otorhinolaryngology nominated, Gastroenterology nominated in the Fudan list.

  3. The First Affiliated Hospital, Zhejiang University School of Medicine浙江大学医学院附属第一医院

    Hangzhou 杭州市

    National key clinical specialty

    Also ranked: General Surgery #7, Urology #9, Infectious Diseases 传染感染 #2 in the Fudan list.

  4. Ruijin Hospital上海交通大学医学院附属瑞金医院

    Shanghai 上海市

    National key clinical specialty

    Also ranked: General Surgery #4, Thoracic Surgery #7 (tied), Respiratory Medicine #5 in the Fudan list.

  5. Beijing Hospital北京医院

    Beijing 北京市

    National key clinical specialty

    Also ranked: Urology nominated in the Fudan list.

  6. Peking University People's Hospital北京大学人民医院

    Beijing 北京市

    National key clinical specialty

    Also ranked: General Surgery #10, Thoracic Surgery #7, Gynecology #7 in the Fudan list.

  7. Peking University Third Hospital北京大学第三医院

    Beijing 北京市

    National key clinical specialty

    Also ranked: Gynecology #4, Urology nominated, Gastroenterology nominated in the Fudan list.

  8. Anhui Provincial Hospital中国科学技术大学附属第一医院（安徽省立医院）

    Hefei 合肥市

    National key clinical specialty

    Also ranked: General Surgery nominated, Otorhinolaryngology nominated in the Fudan list.

Clinical trials (investigational treatments)

In addition to standard care, clinical research studies for Non-Hodgkin lymphoma may currently be open to participants in China. The treatments under study have not been approved by the regulator as standard therapy — they are clinical research, not routine treatment. Each record names the lead investigator and the hospital running the study. If you are interested, contact the hospital to ask about eligibility and choose whether to apply.

  1. Study A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LUCAR-20SP, an Allogenic Chimeric Antigen Receptor(CAR)-T Cell Therapy Targeting CD20 in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

    Hospital
    Peking University Cancer Hospital
    Status
    Recruiting
    Registry
    NCT06313957

This page only shares publicly registered study information. It does not recommend or encourage joining any study. Participation is entirely voluntary and the risks of an unapproved treatment are unknown; contact the hospital directly for eligibility and informed-consent details.

Hospitals with a national key specialty record

Show the hospital records 21 hospitals with a key-specialty record

Each row is a hospital with a national key clinical specialty record in a specialty this condition is filed under. This is a record of published listings, not a recommendation and not a ranking.

Hospital City Specialty (as published) Evidence Source
Ruijin Hospital上海交通大学医学院附属瑞金医院 Shanghai 上海市 Hematology 血液科 Level B https://www.rjh.com.cn/2018RJPortal/lcyxy2019/sy/jj/index.shtml
Beijing Hospital北京医院 Beijing 北京市 Hematology 血液科 Level B https://www.bjhmoh.cn/index.php?id=4&r=archives/about&t=1790009033
Peking University People's Hospital北京大学人民医院 Beijing 北京市 Hematology 血液科 Level B https://www.pkuph.cn/news_details/26715.html
Peking University Third Hospital北京大学第三医院 Beijing 北京市 Hematology 血液内科 Level B https://www.puh3.net.cn/yygk/zdxk.htm
West China Hospital, Sichuan University四川大学华西医院 Chengdu 成都市 Hematology 血液内科 Level A https://wcums.scu.edu.cn/kxyan_jiu/gjlczdzk.htm
Anhui Provincial Hospital中国科学技术大学附属第一医院（安徽省立医院） Hefei 合肥市 Hematology 血液内科 Level B https://www.ahslyy.com.cn/nanqu/col456/892156
Qilu Hospital of Shandong University山东大学齐鲁医院 Jinan 济南市 Hematology 血液内科 Level A http://wsjkw.shandong.gov.cn/wmfw/cxfw/202307/P020230717441794577839.xlsx
Sun Yat-sen Memorial Hospital, Sun Yat-sen University中山大学孙逸仙纪念医院 Guangzhou 广州市 Hematology 地方病科（儿科血液） Level B https://www.gzsys.org.cn/basic/453
The First Affiliated Hospital, Sun Yat-sen University中山大学附属第一医院 Guangzhou 广州市 Hematology 血液内科 Level B https://gcp.fahsysu.org.cn/sites/1h.gcp.sysucloud1.sysu.edu.cn/files/2023-07/20230625%20中山大学附属第一医院宣传折页%20V5.0_0.pdf
Nanfang Hospital南方医科大学南方医院 Guangzhou 广州市 Hematology 血液内科 Level B https://www.nfyy.com/index.html
Guangzhou First People's Hospital广州市第一人民医院 Guangzhou 广州市 Hematology 血液内科 Level B https://oa.gzhosp.cn/col40/list_5
Jiangsu Province Hospital江苏省人民医院（南京医科大学第一附属医院） Nanjing 南京市 Hematology 血液内科 Level B https://www.jsph.org.cn/info/3571/72851.htm
The First Affiliated Hospital, Zhejiang University School of Medicine浙江大学医学院附属第一医院 Hangzhou 杭州市 Hematology 血液内科 Level A http://zdygb.zju.edu.cn/2014/0106/c34026a1762975/page.htm
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology华中科技大学同济医学院附属协和医院 Wuhan 武汉市 Hematology 血液科 Level B https://www.whuh.com/Science/major/gjlczdzkb/2.htm
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology华中科技大学同济医学院附属同济医院 Wuhan 武汉市 Hematology 血液内科 Level B https://www.tjh.com.cn/contents/934/27291.html
Third Xiangya Hospital中南大学湘雅三医院 Changsha 长沙市 Hematology 血液内科 Level B https://www.xy3yy.com/ksjj/184173.html
Second Xiangya Hospital of Central South University中南大学湘雅二医院 Changsha 长沙市 Hematology 血液内科 Level B https://www.xyeyy.com/655/656/664/
Xiangya Hospital of Central South University中南大学湘雅医院 Changsha 长沙市 Hematology 血液内科 Level B https://www.xiangya.com.cn/zdzk.html
Hunan Cancer Hospital湖南省肿瘤医院 Changsha 长沙市 Hematology 淋巴血液肿瘤专科（国家级培育项目） Level B https://hnca.org.cn/wap/zdks/
The First Affiliated Hospital of Chongqing Medical University重庆医科大学附属第一医院 Chongqing 重庆市 Hematology 血液内科 Level B https://www.hospital-cqmu.com/gzb/yygk/yyjj.htm
The First Affiliated Hospital of Xi'an Jiaotong University西安交通大学第一附属医院 Xi'an 西安市 Hematology 血液内科 Level B http://www.dyyy.xjtu.edu.cn/gzbsy/zdxk.htm

21 hospitals with a matching national key specialty record.

Values written in Chinese are quoted as published by the source.

Questions about this condition

We cannot give medical advice, but we can answer questions about this page and about arranging treatment in China.

Ask us about this condition

ICD codes

Show the code table 4 ICD codes
Version Code Name in that version
ICD-10-WHO C82 Follicular lymphoma
ICD-10-WHO C83 Non-follicular lymphoma
ICD-10-WHO C84 Mature T/NK-cell lymphomas
ICD-10-WHO C85 Other and unspecified types of non-Hodgkin lymphoma

Rows are the WHO ICD-10 entries for this condition, quoted as published.

Source & evidence

Source URL
https://www3.ha.org.hk/cancereg/tc/icd10.html
Source scheme
https
Source type
Third-party compilation
Evidence level
A - said by a provincial health commission or university
Retrieved on
2026-10-01